Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Klonoff, M.D, FACP
Diabetes Research Institute, Mills-Peninsula Medical Center, California
Principal InvestigatorKOL profile → - Edward Mahoney, PhD
Becton Dickinson
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mills Pennisula Medical Center-Diabetes Research Institute
San Mateo, California, United States
- Metabolic Research Institute
West Palm Beach, Florida, United States
- East West Medical Research Institute
Honolulu, Hawaii, United States
- Texas Diabetes and Endocrinology
Austin, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Sept 2019
- Primary completion
- 12 Jun 2020
- Completion
- 12 Jun 2020
- Last update posted
- 8 Jul 2021
- Registered enrollment
- 58
- Registry id
- NCT04090242
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.